Impact of novel CFTR modulator on sinonasal quality of life in adult patients with cystic fibrosis

Int Forum Allergy Rhinol. 2021 Feb;11(2):201-203. doi: 10.1002/alr.22716. Epub 2020 Oct 18.

¹ Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania Health System, Philadelphia, PA.
² Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX.
³ Division of Otolaryngology-Head and Neck Surgery, NorthShore University Health System, The University of Chicago, Pritzker School of Medicine, Chicago, IL.
⁴ Department of Medicine, Division of Pulmonary, Allergy, and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

No abstract available

Keywords: CFTR modulator; SNOT-22; chronic rhinosinusitis; cystic fibrosis; elexacaftor; ivacaftor; sinus surgery; tezacaftor.

MeSH terms